Lithium Controlled-Release and Extended-Release Tablets and Samarium Sm 153 Lexidronam
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Samarium Sm 153 Lexidronam and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: samarium sm 153 lexidronam
Brand name: Quadramet
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-Samarium sm 153 lexidronam Intravenous
- Lithium Controlled-Release and Extended-Release Tablets-Samsca
- Lithium Controlled-Release and Extended-Release Tablets-Sanctura
- Lithium Controlled-Release and Extended-Release Tablets-Sanctura XR
- Lithium Controlled-Release and Extended-Release Tablets-Sancuso
- Lithium Controlled-Release and Extended-Release Tablets-Sandimmune
- Samarium Sm 153 Lexidronam-Lithium ER
- Samarium Sm 153 Lexidronam-Lithium Oral Solution
- Samarium Sm 153 Lexidronam-Lithium Salts
- Samarium Sm 153 Lexidronam-Lithium Syrup and Oral Solution
- Samarium Sm 153 Lexidronam-Lithobid
- Samarium Sm 153 Lexidronam-Lithostat